Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Leap Therapeutics, Inc. - Common Stock (NQ:LPTX)

0.3060 -0.0040 (-1.29%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Leap Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
These stocks are moving in today's pre-market session
Discover the top movers in Monday's pre-market session and stay informed about market dynamics. 
Via Chartmill
In today's session, these stocks are experiencing unusual volume.
Unusual volume stocks are being observed in Thursday's session. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Leap Therapeutics: Q4 Earnings Insights
 
Via Benzinga
Recap: Leap Therapeutics Q3 Earnings
 
Via Benzinga
Driving the Future of Healthcare HIT, OSRH, THTX, LPTX, CSDX, Innovations in Health Insurance, Virtual Care, Oncology, and Chronic Disease Treatment
Via AB Newswire
Topics Artificial Intelligence
These stocks are the most active in today's session
Wednesday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity! 
Via Chartmill
Penny Stock Leap Therapeutics Unveils Positive Data From Experimental Combo Therapy For Colorectal Cancer
Leap Therapeutics' Phase 2 trial data show sirexatamab boosts response rates and survival in MSS colorectal cancer, with ongoing business development plans. 
Via Benzinga
Top movers in Wednesday's pre-market session
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
Here’s Why Shuttle Pharma is the Most Undervalued Biotech Stock in Our Coverage Universe
Via Stocktwits
The trading volume of these stocks is deviating from the norm in today's session.
Which stocks have an unusual volume on Wednesday? 
Via Chartmill
This Apple Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
 
Via Benzinga
Top movers analysis one hour before the close of the markets on 2025-01-28: top gainers and losers in today's session.
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements. 
Via Chartmill
Leap Therapeutics Stock Plunges To Record Low After Ending Gastric Cancer Drug Trials, Retail Bets On CRC Pipeline
While sirexatamab combined with tislelizumab and chemotherapy showed some activity in biomarker-specific populations, the study failed to generate a clear positive signal on progression-free survival... 
Via Stocktwits
Leap Therapeutics Halts Sirexatamab Combo Therapy For Gastric Cancer ON Unclear Positive Signal, Stock Crashes
Leap Therapeutics' Phase 2 data shows sirexatamab improves ORR in colorectal cancer. Gastric cancer studies end due to lack of PFS benefit. 
Via Benzinga
Gold Gains 1%; Boeing Shares Rise Following Q4 Results
 
Via Benzinga
These stocks are moving in today's session
Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
Nasdaq Surges More Than 300 Points; Lockheed Martin Shares Dip After Q4 Results
 
Via Benzinga
The market is filled with gapping stocks in Tuesday's session.
Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
Dow Gains Over 50 Points; General Motors Posts Upbeat Earnings
 
Via Benzinga
Topics Stocks
LPTX Stock Earnings: Leap Therapeutics Misses EPS for Q2 2024
LPTX stock results show that Leap Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
LPTX Stock Earnings: Leap Therapeutics Beats EPS for Q1 2024
LPTX stock results show that Leap Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
LPTX Stock Earnings: Leap Therapeutics Beats EPS for Q4 2023
LPTX stock results show that Leap Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Why FLJ Group Shares Are Trading Higher By Around 96%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of FLJ Group Limited (NASDAQ: FLJ) shares jumped during Friday’s session after the company announced it entered into a definitive agreement to acquire Alpha Mind Technology. FLJ Group shares... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Raymond James Maintains Outperform Rating for Leap Therapeutics: Here's What You Need To Know
 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.